510(k) Report

510(k) · Cleared

Cleared

ClearPoint System (Software Version 2.2)

K233243510(k) TraditionalCleared Nov 27, 202360-day reviewClass II21 CFR 882.4560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

ClearPoint Neuro, Inc. · HAW Neurological Stereotaxic Instrument

Cleared on Nov 27, 2023 as substantially equivalent to K222519 (ClearPoint Neuro, Inc., 2022) and 1 other predicate after a 60-day review. Its family tree reaches back 11 generations to 2003. 4 of the 19 devices in its family, counting itself, have a Class I recall. 1 later device descends from it.

Decided
Nov 27, 2023
Review
60 days
Class
Class II
Product code
HAW
Recalls
None
Predicates
2

Its longest line of descent runs back 11 generations to K031815 (2003). 17 ancestors in all, the oldest K001796 (2000). 1 later device descends from it, 1 citing it directly. 4 of the 19 devices in this family, counting this one, have a Class I recall.

  1. Root · 11 generations backK031815 Intera-Sensation FamilyPhilips Medical Systems · 2003 · Recalled
  2. 7 generations between
  3. 3 generations backK171257 ClearPoint SystemMri Interventions, Inc. · 2017
  4. 2 generations backK181195 ClearPoint SystemMri Interventions, Inc. · 2018
  5. 1 generation backK222519 ClearPoint SystemClearPoint Neuro, Inc. · 2022
  6. This deviceK233243 ClearPoint System (Software Version 2.2)ClearPoint Neuro, Inc. · 2023
  7. Descendant · cites it directly · 0 of its ownK243657 ClearPoint System (Software Version 3.0)ClearPoint Neuro, Inc. · 2025
Show all 11 generations
  1. Root · 11 generations backK031815 Intera-Sensation FamilyPhilips Medical Systems · 2003 · Recalled
  2. 10 generations backK041602 Panorama 1.0TPhilips Medical Systems North America, Inc. · 2004 · Recalled (Class I)
  3. 9 generations backK052078 Achieva, Intera and Panorama 1.0 Release 2-SeriesPhilips Medical Systems Nederland B.V. · 2005 · Recalled (Class I)
  4. 8 generations backK063559 Achieva, Intera and Panorama 1.0T, Release 2.5Philips Medical Systems · 2007 · Recalled (Class I)
  5. 7 generations backK100836 Clearpoint SystemSurgivision, Inc. · 2010
  6. 6 generations backK111073 Surgivision Inc. Clearpoint SystemSurgi-Vision, Inc. · 2011
  7. 5 generations backK142505 ClearPoint SystemMri Interventions, Inc. · 2015
  8. 4 generations backK160434 ClearPoint SystemMri Interventions, Inc. · 2016
  9. 3 generations backK171257 ClearPoint SystemMri Interventions, Inc. · 2017
  10. 2 generations backK181195 ClearPoint SystemMri Interventions, Inc. · 2018
  11. 1 generation backK222519 ClearPoint SystemClearPoint Neuro, Inc. · 2022
  12. This deviceK233243 ClearPoint System (Software Version 2.2)ClearPoint Neuro, Inc. · 2023

Class I recalls in this family

Most influential descendants

Showing 1 of 1 · See all
  • K243657ClearPoint System (Software Version 3.0)ClearPoint Neuro, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−11K031815Intera-Sensation FamilyPhilips Medical Systems20033
−10K041602Panorama 1.0TPhilips Medical Systems North America, Inc.2004Class I
−9K052078Achieva, Intera and Panorama 1.0 Release 2-SeriesPhilips Medical Systems Nederland B.V.2005Class I
−8K063559Achieva, Intera and Panorama 1.0T, Release 2.5Philips Medical Systems2007Class I
−7K100836Clearpoint SystemSurgivision, Inc.2010—
−6K111073Surgivision Inc. Clearpoint SystemSurgi-Vision, Inc.2011—
−5K142505ClearPoint SystemMri Interventions, Inc.2015—
−4K160434ClearPoint SystemMri Interventions, Inc.2016—
−3K171257ClearPoint SystemMri Interventions, Inc.2017—
−2K181195ClearPoint SystemMri Interventions, Inc.2018—
−1K222519ClearPoint SystemClearPoint Neuro, Inc.2022—
0 (this device)K233243ClearPoint System (Software Version 2.2)ClearPoint Neuro, Inc.2023—
+1K243657ClearPoint System (Software Version 3.0)ClearPoint Neuro, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
200120
200511
200610
202210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K233243, 2003–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

4 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HAW device

  1. #1 K253856 Geniant Cranial (Navigated Neurosurgical…score 15.0 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K222519ClearPoint System
Summary page 5
…ClearPoint Neuro, Inc. Predicate Device Common Name: Neurological Stereotactic Instrument Predicate Device Premarket Notification # K222519 Predicate Device Classification & Name Neurological Stereotaxic Instrument,…
ClearPoint Neuro, Inc.2022—
*K213645ClearPoint Maestro Brain Model
Summary page 5
…Common Name: System, Image Processing, Radiological Predicate Device Premarket Notification # K213645 Predicate Device Classification & Name Medical Imaging Management and…
ClearPoint Neuro, Inc.2022—

Also cleared against K222519: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K243657ClearPoint System (Software Version 3.0)ClearPoint Neuro, Inc.20250

Has anything in its family been recalled? (4 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K063559Achieva, Intera and Panorama 1.0T, Release 2.5Philips Medical Systems · 2007 · 8 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K052078Achieva, Intera and Panorama 1.0 Release 2-SeriesPhilips Medical Systems Nederland B.V. · 2005 · 9 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K043147Achieva FamilyPhilips Medical Systems North America Co. · 2005 · 9 generations back · ◆ in the 2005 ancestors bar of FIG. 13 Class I recalls
  • K041602Panorama 1.0TPhilips Medical Systems North America, Inc. · 2004 · 9 generations back · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 20 years and passes through 7 companies; a new generation was cleared every 1.2 years on median.
  • 7 of the 17 ancestors have a recall of any class; 4 have a Class I recall.
  • Of its descendants, K243657 (ClearPoint Neuro, Inc., 2025) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K222519.

How does its category compare?

All HAW devices

HAW Neurological Stereotaxic Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · HAW

9in 2025

2007: 152008: 122009: 82010: 62011: 42012: 82013: 32014: 52015: 102016: 92017: 72018: 62019: 102020: 52021: 92022: 72023: 142024: 72025: 92026 (partial year): 5
2007high 15 (2007) · low 3 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HAW

163in 2025

2007: 107 days median2008: 112 days median2009: 221 days median2010: 138 days median2011: 66 days median2012: 178 days median2013: 172 days median2014: 238 days median2015: 232 days median2016: 175 days median2017: 226 days median2018: 112 days median2019: 147 days median2020: 88 days median2021: 168 days median2022: 128 days median2023: 142 days median2024: 107 days median2025: 163 days median2026 (partial year): 162 days median
2007high 238 (2014) · low 66 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HAW

2in 2025

2007: 22008: 102009: 62010: 282011: 52012: 42013: 6, 1 Class I2014: 52015: 32016: 52017: 22018: 2, 2 Class I2019: 4, 1 Class I2020: 12021: 4, 2 Class I2022: 12023: 4, 1 Class I2024: 2, 2 Class I2025: 22026 (partial year): 6
2007high 28 (2010) · low 1 (2020)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · HAW

3,425in 2025

2007: 492008: 532009: 962010: 2992011: 1,7252012: 9862013: 1,2902014: 1,6062015: 1,7672016: 1,8282017: 3,5052018: 4,4392019: 6,0622020: 3,4802021: 2,8272022: 1,9292023: 2,5102024: 3,7552025: 3,425
2007high 6,062 (2019) · low 49 (2007)2025

MAUDE reports naming product code HAW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200715107249
2008121121053
20098221696
2010613828299
201146651,725
201281784986
201331726 (1)1,290
2014523851,606
20151023231,767
2016917551,828
2017722623,505
201861122 (2)4,439
2019101474 (1)6,062
202058813,480
202191684 (2)2,827
2022712811,929
2023141424 (1)2,510
202471072 (2)3,755
2025916323,425
202651626—

What is it indicated for?

The ClearPoint System is intended to provide stereotactic guidance for the placement and operation of instruments or devices during planning and operation of neurological procedures within the MRI environment and in conjunction with MR imaging. During planning, the system is intended to provide functionality for the automatic identification, labeling, visualization and quantification of segmentable brain structures from a set of loaded MR images. The…

Read the full statement (115 words)

The ClearPoint System is intended to provide stereotactic guidance for the placement and operation of instruments or devices during planning and operation of neurological procedures within the MRI environment and in conjunction with MR imaging. During planning, the system is intended to provide functionality for the automatic identification, labeling, visualization and quantification of segmentable brain structures from a set of loaded MR images. The ClearPoint System is intended as an integral part of procedures that have traditionally used stereotactic methodology. These procedures include biopsies, catheter and electrode insertion including deep brain stimulation (DBS) lead placement. The System is intended for use only with 1.5 and 3.0 Tesla MRI scanners and MR conditional implants and devices.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233243: ClearPoint System (Software Version 2.2).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K233243

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026